Related Experiment Video
Updated: Jun 18, 2026

08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Observations on the Radium Treatment of Vesical Carcinoma
Proceedings of the Royal Society of Medicine
|December 9, 2009
Summary
Radium therapy, established by 1914, shows promise for bladder cancer treatment. Research explores fibroblast roles and potential complications, suggesting adjuncts like secondary radiation emitters may improve outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Medical History
Background:
- Review of radium therapy's status in 1913-1914.
- Exploration of fibroblast's role in cancer control.
- Historical context of early 20th-century cancer treatments.
Purpose of the Study:
- To evaluate the historical position and knowledge of radium therapy.
- To investigate the relationship between fibroblasts and cancer.
- To analyze techniques and challenges in treating vesical carcinoma with radium.
Main Methods:
- Review of historical literature and knowledge up to 1914.
- Analysis of fibroblast's role in cancer progression.
- Comparative study of surgical approaches for vesical carcinoma.
- Consideration of potential complications and adjunct therapies.
Main Results:
- Radium therapy was a developing field by 1914.
- Fibroblasts were identified as having a relationship with cancer control.
- Techniques for vesical carcinoma require careful study of approach, sepsis control, and individual cell sensitivity.
- Potential complications include ureteral and iliac vessel damage.
- Secondary radiation-emitting substances may aid radium treatment.
Conclusions:
- Radium therapy's historical application in oncology is reviewed.
- Understanding cellular interactions, like fibroblasts, is crucial for cancer treatment.
- Careful technique and consideration of complications are vital for radium therapy in vesical carcinoma.
- Adjunctive therapies, such as secondary radiation emitters, warrant further investigation.